Gantacurium Chloride

Known as: AV430A 
 
National Institutes of Health

Topic mentions per year

Topic mentions per year

2004-2010
02420042010

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2010
2010
BACKGROUND The ultra-short-acting neuromuscular blocker gantacurium is chemically degraded in vitro by rapid adduction of L… (More)
Is this relevant?
2004
2004
BACKGROUND No replacement for succinylcholine is yet available. GW280430A (AV430A) is a representative of a new class of… (More)
Is this relevant?
2004
2004
BACKGROUND This investigation determined the cardiopulmonary side effects of a novel nondepolarizing neuromuscular blocking drug… (More)
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
Is this relevant?
2004
2004
THE introduction of succinylcholine into clinical practice in 1951 was a seminal development in the history of anesthesia. Since… (More)
Is this relevant?
2004
2004
THE introduction of succinylcholine into clinical practice in 1951 was a seminal development in the history of anesthesia. Since… (More)
Is this relevant?